Back to search

Article

Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrier

2026-06-03

Abstract excerpt

<title>Abstract</title> <p> Background Neuroinflammation and blood–brain barrier (BBB) dysfunction are key contributors to the pathogenesis of many neurological disorders. Cannabinoid receptor 2 (CB <sub>2</sub> ) agonists possess anti-inflammatory properties and may represent promising therapeutic agents for preserving BBB integrity. This study evaluated the effects of novel orally bioavailable CB <sub>2</s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ca14310-4481-5d84-8b46-75841fc744e4
DOI
10.21203/rs.3.rs-9705876/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrierDOI 10.21203/rs.3.rs-9705876/v1
Select a neighboring publication to make it the new centre.